Newborn Screening Panel Extended Test Price 1000 AED
Newborn Screening Panel Test in the UAE:
Welcoming a newborn into the world is a moment of joy and anticipation. In the UAE, parents are progressively seeking state-of-the-art medical care to safeguard their child’s health. The Extended Newborn Screening Panel Test is an essential part of this healthcare journey, providing crucial information about your baby’s health right from the start.
Decoding Newborn Screening: The Foundation of Child Healthcare
Newborn screening is a vital health program conducted soon after birth. It consists of a straightforward blood test to identify certain rare yet severe conditions that may not exhibit symptoms immediately after birth. The standard panel tests for a select number of disorders, while the Extended Panel broadens the detection range.
The Significance of the Extended Newborn Screening Panel Test
The Extended Newborn Screening Panel Test is an all-encompassing assessment that surpasses the standard panel by testing for an expanded set of conditions. Early identification of these disorders is crucial as it enables prompt intervention, averting serious complications and enhancing the child’s life quality.
Disorders Identified by the Extended Panel:
The specific disorders included in the Extended Panel can vary, but it generally covers a wider array of disorders, including:
Metabolic disorders: These interfere with the body’s conversion of food into energy. Hormone disorders: These affect the body’s hormone production and regulation. Hearing loss: Early identification of hearing impairment is vital for language development. Cystic fibrosis: This genetic disorder impacts the lungs and digestive system. Other rare genetic conditions: The panel may incorporate extra tests for specific conditions based on family history or other risk factors.
Advantages of the Extended Newborn Screening Panel Test:
Early Intervention: Early identification of these conditions enables immediate treatment, reducing long-term complications. Enhanced Quality of Life: Prompt intervention can significantly boost the child’s physical and cognitive development. Peace of Mind: Being aware of your child’s health status can offer parents reassurance and peace of mind. Progress in Medical Care: The growing availability of the Extended Panel signifies the UAE’s dedication to providing advanced healthcare for newborns.
Expert Viewpoint: Dr. Aisha Al-Khalifa on Newborn Screening
Dr. Aisha Al-Khalifa, a distinguished pediatrician in the UAE, underscores the importance of newborn screening. “Early detection via the Extended Panel is a fundamental aspect of preventive healthcare. It enables parents to make knowledgeable decisions about their child’s health and gives healthcare providers the chance to intervene promptly and effectively.”
Taking Steps: Safeguarding Your Baby’s Future
The Extended Newborn Screening Panel Test is an invaluable resource for every parent in the UAE. By choosing this thorough screening, you are investing in your child’s health and well-being from the outset. Consult with your pediatrician to decide the best course of action for your family.
Test Name:
NEWBORN SCREENING PANEL EXTENDED Test
Test Components:
- Biotinidase
- Cystic Fibrosis
- G6PD
- Galactosemia
- 17-Hydroxyprogesterone
- TSH
- Tandem Mass Spectrometry – 30 Disorders
Price:
1000.0 AED
Sample Condition:
1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample.
Report Delivery:
Sample Mon / Wed / Fri by 9 am; Report Next day
Method:
TMS, Fluoroimmunoassay
Test Type:
Inborn errors of metabolism
Doctor:
Pediatrician
Test Department:
GENETIC
Pre Test Information:
Clinical details and drug history must accompany sample.
Test Details
The newborn screening panel extended test is a comprehensive screening test performed on newborn babies to detect a wide range of genetic and metabolic disorders. This test is an extension of the standard newborn screening panel, which typically includes tests for conditions like phenylketonuria (PKU) and congenital hypothyroidism. The extended test includes additional tests that can detect a larger number of disorders.
These disorders may include metabolic disorders, such as organic acidemias, fatty acid oxidation disorders, and amino acid disorders. It may also include tests for genetic disorders, such as cystic fibrosis, sickle cell disease, and spinal muscular atrophy.
The purpose of the extended newborn screening panel is to identify these disorders early on, so that treatment can be initiated as soon as possible. Many of these disorders are not apparent at birth and may not present symptoms until later in infancy or childhood. By detecting them early, healthcare providers can intervene and provide appropriate treatment and management strategies to prevent or minimize the potential complications associated with these disorders.
The extended newborn screening panel is typically performed using a blood sample obtained from a heel prick. The blood sample is then sent to a laboratory for analysis. Results are usually available within a few weeks, and if any abnormalities are detected, further testing may be recommended to confirm the diagnosis.
It is important to note that the specific tests included in the extended newborn screening panel may vary depending on the country or state where the test is performed. Healthcare providers can provide more information on the specific tests included in their screening panels.
| Test Name | NEWBORN SCREENING PANEL EXTENDED Test |
|---|---|
| Components | *Biotinidase*Cystic Fibrosis*G6PD *Galactosemia*17-Hydroxyprogesterone *TSH *Tandem Mass Spectrometry – 30 Disorders |
| Price | 1000.0 AED |
| Sample Condition | 1 drop of heel prick blood each on 3 spots of filter paper available from LPL. Ship refrigerated or frozen. Clinical details and drug history must accompany sample. |
| Report Delivery | Sample Mon / Wed / Fri by 9 am; Report Next day |
| Method | TMS, Fluoroimmunoassay |
| Test type | Inborn errors of metabolism |
| Doctor | Pediatrician |
| Test Department: | GENETIC |
| Pre Test Information | Clinical details and drug history must accompany sample. |
| Test Details | The newborn screening panel extended test is a comprehensive screening test performed on newborn babies to detect a wide range of genetic and metabolic disorders. This test is an extension of the standard newborn screening panel, which typically includes tests for conditions like phenylketonuria (PKU) and congenital hypothyroidism.
The extended test includes additional tests that can detect a larger number of disorders. These disorders may include metabolic disorders, such as organic acidemias, fatty acid oxidation disorders, and amino acid disorders. It may also include tests for genetic disorders, such as cystic fibrosis, sickle cell disease, and spinal muscular atrophy. The purpose of the extended newborn screening panel is to identify these disorders early on, so that treatment can be initiated as soon as possible. Many of these disorders are not apparent at birth and may not present symptoms until later in infancy or childhood. By detecting them early, healthcare providers can intervene and provide appropriate treatment and management strategies to prevent or minimize the potential complications associated with these disorders. The extended newborn screening panel is typically performed using a blood sample obtained from a heel prick. The blood sample is then sent to a laboratory for analysis. Results are usually available within a few weeks, and if any abnormalities are detected, further testing may be recommended to confirm the diagnosis. It is important to note that the specific tests included in the extended newborn screening panel may vary depending on the country or state where the test is performed. Healthcare providers can provide more information on the specific tests included in their screening panels. |
